Skip to content
Screener

Carlsmed, Inc. CARL Unpaid Deferred Offering And Issuance Costs

Unpaid Deferred Offering And Issuance Costs at other companies

Hinge Health logo
Hinge HealthHNGE
$0
AMC Robotics Corporation logo
AMC Robotics CorporationAMCI
$83.57K
STU
StubHub HoldingsSTUB
$352K-95.0%
GPA
General Purpose Acquisition Corp.GPAC
$652.31K
Hinge Health logo
Hinge HealthHNGE
$0
Mineralys Therapeutics, Inc. logo
Mineralys Therapeutics, Inc.MLYS
$200K-33.3%

Other financials

Income statement

See full
Revenue$18.9M+56.7%
Gross profit$14.5M+64.0%
Operating income-$11.0M-69.7%
Net income-$10.5M-55.3%
EPS (diluted)-$0.39+73.5%

Balance sheet

See full
Cash & equivalents$46.2M+38.2%
Total debt$21.9M+23.8%
Total equity$84.2M+201%
Total assets$118.2M+122%

Cash flow

See full
Operating cash flow-$7.4M-4.5%
CapEx$121.0K-63.0%
Free cash flow-$7.5M-1.5%

Valuation

See full
Market cap$377.32M+11.9%
Enterprise value$353M
P/S

Profitability

See full
Gross margin76.6%+2.6pp
Operating margin-61.1%-3.1pp
Net margin-57.4%-6.2pp
FCF margin-54.6%-10.6pp

Returns & leverage

See full
Return on equity-6,196.9%
Debt / equity0.3×
Current ratio8.8×+4.0×

Where this comes from

Reported directly by Carlsmed, Inc. in its filing.

Tagged under the XBRL concept carl:UnpaidDeferredOfferingAndIssuanceCosts.

The source filing: Carlsmed, Inc.’s 10-Q, filed August 5, 2026. Open the filing →

Filed
Aug 5, 2026, 4:10 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001794546-26-000016

FAQ

What is Carlsmed, Inc.'s unpaid deferred offering and issuance costs?
Carlsmed, Inc. (CARL) reported unpaid deferred offering and issuance costs of $144K in Q2 2026.
What does unpaid deferred offering and issuance costs mean?
Unpaid Deferred Offering And Issuance Costs as reported by Carlsmed, Inc..

Ask your AI about Carlsmed, Inc.'s unpaid deferred offering and issuance costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude